Tango Therapeutics
TNGX
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.34 | -0.35 | -0.01 | -2.94% |
| Revenue | 8.02M | 4.12M | -3.90M | -48.67% |
WhatIF - Earnings
EPS Missed Expectations by -$0.01
Tango Therapeutics (TNGX:NASDAQ) has never missed EPS by this much before
There’s a first time for everything